We investigated the cellular expression of 9 cytochrome P450-isozyme s (CYP1A1, CYP1A2, CYP2B6, CYP2C8,9,19, CYP2D1, CYP2E1, CYP3A1, CYP3A2, CYP3A4) and 3 glutathione S-transferase-isozyme s (GST-p , GST-a , GST-l ) in the pancreas of hamsters, mice, rats, rabbits, pigs, dogs and monkeys, and in comparison with the human pancreas. A wide variation was found in the cellular localization of these enzymes between the 8 species. Most enzymes were expressed in the pancreas of the hamster, mouse, monkey and human, whereas rats, pigs, rabbits and dogs were lacking several isozymes. However, in all of the species the islet cells expressed more enzymes than ductal and acinar cells. An exclusive expression of enzymes in the islet cells was found in the hamster (CYP2E1), mouse (CYP1A1, CYP1A2, GST-a , GST-l ), rat (CYP2C8,9,19), rabbit (CYP1A2, CYP2B6, GST-p ), and pig (CYP1A1). Although no polymorphis m was found in the pancreas of animals, in human tissue four enzymes were missing in about 50% of the cases. The results imply a greater importance of the islet cells in the metabolism of xenobiotics within the pancreas. The differences in the distribution of these drug-metabolizin g enzymes in the pancreas between the species call for caution when extrapolating experimental results to humans.
INTRODUCTION
Laboratory animals, including hamsters, mice, rats, rabbits, pigs, dogs, and monkeys have been used for chemical safety evaluations, carcinogenesis studies, or as a preclinical model for cancer therapy. It appears that rodents in general are more susceptible to carcinogens than carnivores, primates, and humans (1, 3, 15, 17, 18, 30, 35, 51) . These differences have been attributed, in part, to differences of the life span and tumor latency between species, but also to species differences in the metabolism of the carcinogens (5, 31, 39, 50) , which is governed primarily by phase I and phase II enzymes. The activity of phase I enzymes [eg, cytochrome P450 mono-oxygenases (CYP)] results in the formation of either more reactive compounds or of substrates for further conjugation by the phase II enzymes (24, 30) . Phase II enzymes are made up of numerous transferases such as glutathione S-transferases (GST), which detoxify electrophilic compounds and the products of phase I metabolism (6, 7, 10, 27, 28) . Four main classes of GST isozymes exist, a , l , p , and h (24, 33, 36) , with more than 90% of the GST-content being represented by GST-a , l , and p (4) . Although the pattern of drug metabolizing enzymes in some tissues, especially in the liver, has been investigated, little information is available for the CYP pattern of the pancreas.
In hamsters, but not in mice and rats, N -nitrosobis (2-oxopropyl)amine (BOP) induces pancreatic adenocarcinomas, which in morphological, biological, and clinical aspects mimic the human disease (32, 41, 46) . To understand the reasons for the resistance of rats' and mice' pancreases to the carcinogenic effect of BOP, in a previous study we examined the distribution and cellular localization of selected CYPs and GSTs in the pancreases of these species in comparison with that of hamsters. Although the study could not clarify the reasons for species differences in the carcinogenic response, it demonstrated a striking variation in the cellular distribution of the enzymes in the pancreas of the 3 rodents. Remarkably, however, in all 3 species most CYPs and GSTs were expressed in the islet cells. The present study is an extension of our comparative investigation on the cellular distribution of selected drug-metabolizing enzymes in the pancreas of the species that are used as test animals in drug and toxicity studies in comparison with their pattern in the human pancreas. To our knowledge, nothing is known about the distribution of CYPs and GSTs in the pancreata of the rabbit, pig, dog, and monkey.
METHODS

Animals
Normal human pancreatic tissue (n 21, 10 males and 11 females) was obtained from organ donors and from early autopsies with an average age of 44.7 years (range: 1-84 years). The average age of the male specimens was 50 years, in contrast to the average age of 40 years of the female specimens. The pancreata from male Syrian Golden Hamsters and 247 0192-6233/02$3.00 $0.00 from male Wistar rats were obtained from the Eppley animal breeding facilities, male nude nu/nu mice were obtained from the NIH, male rabbits, dogs, guinea pigs, and Macaque monkeys, each, from the animal facility at the University of Nebraska Medical Center. Hamsters, rats, mice, and guinea pigs were each 8 weeks old at time of euthanasia. They were kept in plastic cages on corncob bedding with free access to food (Teklad 8064 rodent diet, Harland Teklad, Madison, WI) and tap water ad libidum. Nude mice were housed under speci c pathogen-free conditions in sterilized plastic containers covered with polyester bacterial air lters. Rabbits (3-monthold), monkeys (12-month-old), and dogs (9-month-old) were maintained in adequate cages and received Teklad 2031 high ber rabbit diet, Teklad 2050 primate diet, or Diamond dog food (Ralston Purina, St. Louis, MO), respectively. All pancreases were obtained from untreated control groups. Histological examination of their pancreata did not show any pathological alterations. The 21 human specimens and 5 pancreata from each species were xed in 10% buffered formalin, embedded in paraf n wax by conventional methods, cut into serial sections of 4 l m in thickness, and were processed for immunohistochemistry.
Antibodies and Chemicals
The polyclonal anti-GST-p , -GST-a , and -GST-l antibodies were purchased from Novocastra (Vector Laboratories Inc, Burlingame, CA); polyclonal anti-CYP1A1, -CYP1A2, -CYP2B6, -CYP2C8,9,19, -CYP2D1, -CYP2E1, -CYP3A1, -CYP3A2, and -CYP3A4 antibodies from Chemicon, Temecula, California; anti-glucagon, -insulin, and -somatostatin from Zymed, South San Francisco, California, and supersensitive rabbit or mouse control antibodies from Biogenex, San Ramon, California. The DAB reagent set and Histomark Blue were obtained from Kirkegaard and Perry Laboratories, Gaithersburg, Maryland.
Although the speci city of the anti-GST and -CYP antibodies was assured by the manufacturers, (www.chemicon. com, www.novocastra.com), we examined their speci cities by comparing the immunohistochemical results with these antibodies in cultured human islet cells and rat liver with the results of Western blotting and RT-PCR (unpublished observations).
Immunohistochemistry
Immunohistochemistry was performed by the avidinbiotin-peroxidase complex (ABC) method. To examine the localization of the enzymes in speci c islet cells, double immunostaining was performed with each of the antibodies against a given enzyme plus anti-insulin, anti-glucagon, or anti-somatostatin as described (42) . Dilutions for the primary antibodies were as follows: GST-p 1:25, GST-a 1:50, and GST-l 1:100 and all CYP's 1:300. In a pilot study, these concentrations were found to be optimal without any nonspeci c reactivity. The staining intensity was evaluated as none ( ), weak ( ), moderate ( ), or strong ( ). The pattern of immunoreactivity was diffuse cytoplasmic unless otherwise noted. Immunostaining of tissues from all species with a given antibody was performed simultaneously as a batch under the identical condition. For clari cation and consistency of results, the same procedure was carried out at another time in the serial sections of the unstained slides of the same tissue. When improper staining (lack of staining, patchy staining, different staining patterns between the tissue samples of the same species) was noticed, additional sections were stained until the staining patterns were found to be consistent in 2 consecutive slides. The slides were evaluated by 2 observers in a blind fashion. If inconsistencies were found, more slides were processed with the same antibody. With this procedure, the interobserver variation was < 1%. Control slides were processed similarly except that a nonimmunized serum was used instead of the primary antibody.
RESULTS
A wide variation in the cellular localization and the staining intensity of the enzymes was found between the species (Tables 1-3) .
Phase I Drug-Metabolizing Enzymes
CYP1A1 was expressed in the ductal and acinar cells of all but mice, pigs, and hamsters, and in the islet cells of all species. In the monkey the immunoreactivity of acinar cells was of a zymogen type. The staining intensity was stronger in about 50% of the islet cells in rabbits and in around 15% of the islet cells in 3 out of 21 human specimens. In both species, these strongly stained islet cells were of a -type. Only in pigs the staining pattern of the islet cells was of a Golgi pattern. CYP1A2 immunoreactivity was detected only in the ductal cells of hamsters and humans, in the acinar cells of hamsters, rats, dogs, monkeys, and humans, and in the islet cells of ham- sters, mice, rats, rabbits, and humans (Tables 1-3 ). In the dog, monkey, and in 2 humans, the reactivity in acinar cells was of Golgi type, as it was also in the islet cells of the 2 humans specimens (Figure 1b) . The number of immunoreactive islet cells within each islet differed between the species. In hamsters the immunoreactivity was restricted to over 50% of the islet cells (Figure 1a) . In mice, 20% of the islet cells, which were stained stronger than the other islet cells, were identi ed as a -cells.
CYP2B6 was expressed differently in the ductal and acinar cells of the species (Tables 1-3 ). In the dog, the reactivity was of zymogen type. The islet cells of all species but the dog immunoreacted with the antibody. In the hamster 40% to 60% and in the rabbit and pig, each, 30-50% of the islet cells, identi ed as a -cells, were stained with a strong intensity. However, and as with the other antibodies, not every a -cell immunoreacted with the antibody (Figure 2) . Moderate immunoreactivity of all islet cells was found in mice, rats, and monkeys. A stronger staining intensity than in the rest of the islet was seen in the a -cells of rats ( 5% of islet cells) and monkeys ( 30%). CYP2C8,9,19 was expressed in ductal and acinar cells of some species and in the islet cells of all species but rabbit and dog (Tables 1-3 ). The reactivity of ductal cells in 3 human cases was of a Golgi type and of acinar cells in pigs of a zymogen type. The isozyme was expressed exclusively in the a -cells of pigs (40% of islet cells), whereas in rats, a -cells expressed the isozyme in a stronger intensity than the FIGURE 4.-The immunoreactivity of anti-CYP2E1 with the pancreas of a hamster (a), rat (b), mouse (c), and human (d). In the hamster the reactivity was restricted to the islet cells, whereas in the rat and mouse a weaker immunoreactivity was seen in ductal/ductular cells and in humans of acinar cells. In the mouse, membrane staining of ductal cells was also noticed (arrow). In the rat, acinar cell nuclei were stained. Note that in the rat (b) and mouse the islet cells corresponding to the a -cells are stained stronger. ABC method 75.
other islet cell types (Figure 3a) . In the human tissue the islet cells of all but 2 specimens were stained weakly, but in the 2 specimens 40% of the cells immunoreacted strongly.
CYP2D1 immunoreactivity was observed in the ductal, acinar and islet cells of all species except in the acinar cells of the rat and rabbit. In the dog, the immunoreactivity of acinar cells was of the zymogen type. In 2 human tissues that did not express CYP2D1 in their acinar cells, the staining was restricted to the islet and ductular cells. In general, islet cells in humans were stronger stained than ductal, ductular, and acinar cells (Figure 3b) .
CYP2E1 expression was noticed in the ductal, acinar and islet cells of mice, rats, and humans and in the islet cells of hamsters (Figure 4) . In rats, the nuclei of the acinar cells were also stained (Figure 4b) . In human tissues, the lack of expression was found in acinar and ductal cells of 3 specimens and in the islet cells of 4 specimens. The staining of vessel walls (adventitia) was found in the dog and monkey.
An immunoreactivity with anti-CYP3A1 was found in ductal, acinar, and islet cells of all species except for islet cells in the pig. In hamsters 50%, in humans up to 25%, and in dogs 3% of the islet cells (identi ed as a -cells) immunoreacted stronger than the other islet cell types (Figure 5a ).
CYP3A2 was expressed in the ductal and islet cells of all and in the acinar cells of all but the monkey (Tables 1-3 ). In the rabbit and dog the staining of the acinar cells was of the zymogen type. The staining of islet, ductal, and acinar cells in humans was of a diffuse cytoplasmic type. In mice, 3% of the islet cells (a -cells) immunoreacted stronger than the remaining islet cells.
More acinar cells than ductal cells expressed CYP3A4 (Tables 1-3 ). The immunoreactivity in the acinar cells of the rabbit was of zymogen type. The islet cells of rabbits, pigs, dogs, and monkeys lacked the expression of the isozyme. None of the pancreatic epithelial cells of the dog showed any immunoreactivity with the antibody. In all human specimens, a weak-to-moderate staining of all islet cells was observed. A stronger staining of up to 25% of the islet cells, most of them were identi ed as a -cells, was found in 5 human tissues. 
Phase II Drug-Metabolizing Enzymes
GST-p expression was noticed in ductal cells of all animals but rabbits and in the islet cells of all but pigs (Tables 1-3) . No immunoreactivity was found in the acinar cells of any species (Tables 1-3 ). In mice a stronger staining was found in a -cells, and in humans, the isozyme was exclusively expressed by the a -cells.
GST-a was expressed in the ductal cells of all species but the mouse and rabbit, in the acinar cells of the pig, monkey, and human and in the islet cells of the hamster, mouse, and human. However, in 7 human specimens, the islet cells did not immunoreact with the antibody, whereas in the remaining 14 tissues up to 10% of the islet cells, identi ed as a -cells, were stained.
An promptedimmunoreactivity with anti-GST-l was seen in the ductal cells of all species, in acinar cells of humans and in the islet cells of all but the dog (Tables 1-3) . However, the expression of this isozyme was found in only 11 human specimens. In pigs, the isozyme was selectively expressed in 20% of the islet cells (a -cells). In rabbits, 5-10% of the islet cells (a -cells) immunoreacted strongly. There were no differences in the immunoreactivity of the GST antibodies between the sex and age, nor was there any difference between the tissues from the organ donors and autopsy cases (data not shown).
The average number of drug-metabolizing enzymes in the pancreatic compartments is summarized in Table 4 .
Ductal Cells: Hamsters and humans expressed the most drug-metabolizing enzymes (10 enzymes), followed by rats Ductal cells  10  7  9  6  7  7  9  10  Acinar cells  8  7  4  5  7  7  8  9  Islet cells  11  12  10  8  6  5  9  10 and monkeys (both 9 enzymes), mice, pigs, and dogs (each 7 enzymes) and rabbits (6 enzymes).
Acinar Cells: Humans expressed 9 enzymes, hamsters and monkeys 8 enzymes, mice, pigs, and dogs 7, rabbits 5, and rats 4 enzymes.
Islet Cells: Mice expressed 12 enzymes, hamsters 11, humans and rats 10, monkeys 9, rabbits 8, pigs 6, and dogs 5 enzymes.
Overall, the most drug-metabolizing enzymes were expressed within the islet cells (an average of 9 enzymes per islet and species), followed by ductal cells (8 enzymes per species) and acinar cells (7 enzyme per species). The staining intensity appeared to be stronger within the islets than in the other pancreatic cells. Control slides were not stained in any tissue.
DISCUSSION
In a previous study, we investigated the cellular localization of selected CYP 450-isozymes, which are believed to play a role in the xenobiotic metabolism within the gastrointestinal tract, in the pancreas of hamster, mouse, and rat (unpublished). Signi cant differences were found in the presence and cellular distribution of some enzymes between these 3 rodents. The results prompted us to examine the patterns of these drug-metabolizing enzymes in the pancreas of the other laboratory species, rabbit, pig, dog, and monkey, which serve as test objects for toxicological studies including chemical safety evaluation and carcinogenicity experiments.
For this study, we selected phase I and II biotransforming enzymes, which are believed to play an important role in the detoxi cation/activation process. The activation of various nitrosamines in the liver has been linked to CYP1A1/1A2, CYP2B6, CYP2E1, and CYP3A4 isoforms (22, 23, 37) . Substrates for CYP1A1, CYP1A2, and CYP2B6 are also polycyclic aromatic hydrocarbons and heterocyclic amines (23) . CYP2D1, CYP3A1, CYP3A2, and CYP3A4 have been shown to metabolize many xenobiotics, including a number of chemical carcinogens and therapeutic agents (2, 12, 25, 48, 49, 55) . CYP2C8,9,19 is known to metabolize various drugs within the gastrointestinal tract (8, 43, 44, 53) . The phase II system is made up by glutathione S-transferases, which are involved in the detoxi cation but not activation of xenobiotics.
The polyclonal antibodies we used have been tested for their substrate speci city by the manufacturers. Moreover, a close correlation between our ndings and those reported by other investigators (9, 11, 13, 16, 38, 54, 56) , and the high homology of the enzymes between the species excludes a non-speci city of the antibodies (30) . Although the antibodies used are targeted towards a small unique region of the native protein, which makes a cross reactivity unlikely, because of the considerable similarities in the primary structure of enzymes within a CYP family, a cross-detection between 2 forms from the same subfamily cannot be ruled out entirely. Therefore, we used RT-PCR and immunoblot analysis to examine the speci city of the antibodies and found that except for CYP 1A2 and CYP 3A4 all antibodies were speci c (unpublishe d observations). Other biochemical techniques, including the activity measurement of enzymes, require not only the isolation of individual cell types, but also the separation of individual components of a structure, such as islets. Presently, there are no methods for such subtle studies. One should also bear in mind that the isolation technique, such as the use of collagenase, can alter the enzymatic patterns of the cells in various degrees. Studies on cultured cells, if available, also have their limitations, because of the possible modi cation of the drug-metabolizing enzymes in arti cial conditions. The in situ hybridization technique provides another possibility, when all probes for the enzymes become available. Consequently, immunohistochemistry is presently the best available method for such detailed investigations, although this technique has its own limitations.
As in our previous study, a wide variation in the distribution and cellular localization of the selected drug-metabolizing enzymes was found between the 8 species on one hand and between the pancreases of humans on the other hand. In humans, a genetic polymorphism has been reported for CYP1A1, CYP2C9, GST-P1 (gene 1 of GST-p ), GST-M1, GST-M3 (M1 and M3 represent 2 of the 5 GST-l genes), and GST-T1 (gene 1 of two GST-h genes) (20, 24) . As shown in Tables 1-3 , seven of the enzymes showed differences in their expression in the human specimens. The differences could be related to several factors, including exposure to different substrates, nutrition and ethnic differences [eg, more Asians than Caucasians have inactive alleles of CYP 2C19 (19) ]. Moreover, the nding could re ect the existence of a circadian rhythm in the enzyme activation, as has been shown in the liver (26, 34, 40) . Further studies are required to understand this complex issue.
Controversy exists about the genetic polymorphism of CYP2E1, because no correlation could be found between variant alleles and its expression in vitro or in vivo (20, 24) . In contrast to humans, no interindividual differences existed between animals of the same strain.
Most enzymes were expressed in the pancreas of the human, hamster, mouse, and monkey. Rats, pigs, rabbits, and dogs, on the other hand, were lacking several isozymes. Islet cells of all 8 species expressed more enzymes than ductal and acinar cells. Moreover, the staining intensity, a possible indicator of enzyme concentration, was stronger in islet cells than in the exocrine cells. Only in pigs and dogs fewer isozymes were found within the islets than in the other cells. The presence of many isozymes in the islet cells of all species, and their exclusive expression in the islet cells of hamster (CYP2E1), mouse (CYP1A1, CYP1A2, GST-a ), rabbit (CYP1A2, CYP2B6, GST-p ), and pig (CYP1A1), implies a greater importance of the islet cells in the metabolism of xenobiotics within the pancreas. This might be explained by the blood supply of the pancreas as discussed elsewhere (52) .
Despite some similarities in the expression of the CYP enzymes between the species extreme care is needed when extrapolating the test results gathered from these animals to humans (22, 29) . Among the very closely related proteins there may be considerable catalytic differences (45) . Even between the rodents, like rat and mouse, there is little comparison in the metabolic pathways for activation and detoxi cation of xenobiotics including carcinogens (14, 30, 47) . Moreover, it appears that the metabolic capacity of the same tissue from different species varies considerably, as does the localization of the enzymes in different cells of the same tissue in the same species.
